Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of morphine action by lauric acid

T Miwa1, K Nakao, M Takahashi

  • 1Department of Pharmacology, Faculty of Pharmaceutical Sciences, Nagasaki University, Japan.

Biological & Pharmaceutical Bulletin
|August 1, 1993
PubMed
Summary

Lauric acid (C12) shows a dose-dependent pain-relieving effect and can prevent morphine tolerance in mice. Its specific dosage is crucial for modulating pain inhibition systems.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased plasma aldosterone levels in patients with type 2diabetes mellitus: A possible pitfall in diagnosis of primary aldosteronism.

Diabetes & metabolism·2019
Same author

Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis: A possible useful diagnostic biomarker.

Diabetes & metabolism·2019
Same author

Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure.

Diabetes & metabolism·2018
Same author

Increase in cortisol/ACTH ratio after chronic treatment with liraglutide in patients with type 2 diabetes.

Diabetes & metabolism·2017
Same author

Low bilirubin levels are an independent risk factor for diabetic retinopathy and nephropathy in Japanese patients with type 2 diabetes.

Diabetes & metabolism·2015
Same author

Transforming growth factor β1 T868C gene polymorphism is associated with cerebral infarction in Japanese patients with type 2 diabetes.

Diabetes research and clinical practice·2011

Area of Science:

  • Pharmacology
  • Neuroscience
  • Biochemistry

Background:

  • Pain management often involves opioids, but tolerance can limit their long-term efficacy.
  • Endogenous pain inhibitory systems play a role in modulating pain perception.
  • Medium-chain fatty acids, like lauric acid (C12), are being investigated for their potential biological roles.

Purpose of the Study:

  • To investigate the antinociceptive effects of lauric acid (C12).
  • To determine if lauric acid (C12) modulates the effects of morphine.
  • To explore the potential role of lauric acid (C12) in the endogenous pain inhibitory system.

Main Methods:

  • Intraperitoneal administration of varying doses of lauric acid (C12) in mice.
  • Assessment of antinociceptive effects using standard pain assays.
  • Co-administration of lauric acid (C12) with morphine to evaluate modulatory effects and tolerance development.

Main Results:

  • High doses of lauric acid (C12) exhibited a weak, dose-dependent antinociceptive effect.
  • A specific low dose of lauric acid (C12) tended to suppress morphine's antinociceptive effect.
  • Daily administration of this lauric acid (C12) dose with morphine prevented the development of antinociceptive tolerance to morphine.
  • Deviations from the specific lauric acid (C12) dose abolished its modulatory effect on morphine.

Conclusions:

  • Lauric acid (C12) demonstrates a dose-dependent influence on pain perception and opioid response.
  • The precise dosage of lauric acid (C12) is critical for its modulatory effects on morphine analgesia and tolerance.
  • These findings suggest a regulatory role for lauric acid (C12) within the body's natural pain-inhibiting mechanisms.

Related Experiment Videos